Author Index: J

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jagsi, R.
• FACTORS ASSOCIATED WITH DECISIONS FOR CONTRALATERAL PROPHYLACTIC MASTECTOMY
Jahn, B.
• WHEN IS ENOUGH EVIDENCE ENOUGH? VALUE-OF-INFORMATION ANALYSIS FOR PRIORITIZING ADDITIONAL OUTCOMES RESEARCH ON THE TREATMENT OF CHRONIC MYELOID LEUKEMIA
Jalal, H.
• AUTOMATING IDENTIFICATION OF MULTIPLE CHRONIC CONDITIONS IN CLINICAL PRACTICE GUIDELINE RECOMMENDATIONS
• SOME HEALTH STATES ARE CERTAINLY BETTER THAN OTHERS: USING HEALTH STATE RANK ORDER TO IMPROVE PROBABILISTIC SENSITIVITY ANALYSES
• SENSITIVITY ANALYSIS USING LINEAR REGRESSION METAMODELING
Jamieson, F.
• ESTIMATING THE HEALTHCARE COSTS ATTRIBUTABLE TO INVASIVE MENINGOCOCCAL DISEASE
Jamison, D.
• TASK-SHARING OR PUBLIC FINANCE FOR THE EXPANSION OF SURGICAL ACCESS IN RURAL ETHIOPIA: AN EXTENDED COST-EFFECTIVENESS ANALYSIS
Janssen, P.
• USABILITY TESTING OF A PATIENT EDUCATION TOOL FOR VAGINAL BIRTH AFTER CESAREAN (VBAC)
Jayasekera, J. C.
• RACIAL DISPARITIES IN CONTEXT: A MULTILEVEL ANALYSIS OF CONSERVATIVE MANAGEMENT IN MEN WITH LOW RISK PROSTATE CANCER
• RACIAL DISPARITIES IN CONTEXT: A MULTILEVEL ANALYSIS OF EARLY TREATMENT PATTERNS AMONG MEN WITH HIGH RISK PROSTATE CANCER
Jazwinski, A. B.
• MAKING HEPATITIS C A RARE DISEASE IN THE UNITED STATES: MODEL-BASED PREDICTIONS
Jegathisawaran, J.
• FRAMEWORKS TO SELECT THE APPROPRIATE MODELLING APPROACH FOR DECISION-ANALYTIC ECONOMIC EVALUATIONS—DO DIFFERENT MODELLING APPROACHES LEAD TO DISPARATE RESULTS?
Jiang, M.
• COST EFFECTIVENESS ANALYSIS OF SYSTEMATIC REFERRAL TO MULTIDISCIPLINARY WOUND CARE TEAMS IN ONTARIO. EVIDENCE FROM THE WOUND INTERDISCIPLINARY TEAMS (WIT) TRIAL
Jimbo, M.
• APPLICATION OF THE READY, WILLING, AND ABLE MODEL TO DECISION AID IMPLEMENTATION
• CULTURE AND PATIENT-CENTERED DECISION-MAKING AMONG DIVERSE POPULATIONS
Johansson, K. A.
• TASK-SHARING OR PUBLIC FINANCE FOR THE EXPANSION OF SURGICAL ACCESS IN RURAL ETHIOPIA: AN EXTENDED COST-EFFECTIVENESS ANALYSIS
John-Baptiste, A.
• DOES FIRST LINE THERAPY WITH AROMATASE INHIBITORS INCREASE THE RISK OF HIP FRACTURES AMONG POSTMENOPAUSAL WOMEN WITH EARLY STAGE BREAST CANCER? A META-ANALYSIS
Johnson, H.
• ESTIMATED HEALTH AND ECONOMIC IMPACT OF IMMUNIZATION AGAINST VACCINE-PREVENTABLE DISEASES RELATED TO TEN ANTIGENS IN 73 COUNTRIES DURING THE DECADE OF VACCINES (2011-2020)
Johnson, R.
• THE VALUE OF FAME AND SHAME: DRUG-DIVERSION INCENTIVES AND DISINCENTIVES IN SPORT
Johnson, R.
• WHERE PATIENTS STAND DEPENDS ON WHERE THEY SIT: CURRENT HEALTH STATUS AND TOLERANCE FOR THERAPEUTIC RISKS
Jones, B.
• TREATMENT DECISIONS IN PRIMARY CARE FOR VETERANS WITH UPPER RESPIRATORY INFECTIONS: A CRITICAL DECISION METHOD
Jones, C.
• A SYSTEM DYNAMICS APPROACH TO OPTIMIZING RESOURCE ALLOCATION IN KIDNEY DIALYSIS VERSUS TRANSPLANTATION
Jones, M.
• TREATMENT DECISIONS IN PRIMARY CARE FOR VETERANS WITH UPPER RESPIRATORY INFECTIONS: A CRITICAL DECISION METHOD
Joore, M.
• SHOULD PATIENTS PRESCRIBED LONG-TERM LOW-DOSE ASPIRIN RECEIVE PROTON PUMP INHIBITORS? SYSTEMATIC REVIEW AND META-ANALYSIS
Joranger, P.
• DEVELOPMENT AND VALIDATION OF A NORWEGIAN MODEL FOR COLORECTAL CANCER
Jull, J.
• ARE PATIENTS' VIEWS AND CULTURAL BACKGROUND TAKEN INTO CONSIDERATION IN THE DEVELOPMENT OF INSTRUMENTS THAT ASSESS SHARED DECISION MAKING OUTCOMES?: A SYSTEMATIC REVIEW TO INFORM RHEUMATOLOGY PRACTICE AND RESEARCH
Jungheim, E.
• IN VITRO FERTILIZATION INSURANCE COVERAGE AND CHANCES OF A LIVE BIRTH
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z